Mutant Tyrosine Kinases with Unnatural Nucleotide Specificity Retain the Structure and Phospho-Acceptor Specificity of the Wild-Type Enzyme
Laurie Witucki(Princeton University), Kevan M. Shokat(Howard Hughes Medical Institute), Kavita Shah(Purdue University West Lafayette), Yi Liu(Monash University), Xin Huang(Amgen (United States)), Saw Kyin(Princeton University), Michael J. Eck(Harvard University)
Cited by 64
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k